.. Évaluations-médico-Économiques, I. Étude, . De-faisabilité-d-'une-méthode, . De, and .. De-la-fa-paroxystique, 34 A) INTRODUCTION, p.34

S. Chugh, R. Havmoeller, K. Narayanan, D. Singh, M. Rienstra et al., Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study, Circulation, vol.129, issue.8, pp.837-884, 2014.
DOI : 10.1161/CIRCULATIONAHA.113.005119

K. Chevreul, I. Durand-zaleski, A. Gouépo, E. Fery-lemonnier, M. Hommel et al., Cost of stroke in France, European Journal of Neurology, vol.260, issue.7, pp.1094-100, 2013.
DOI : 10.1007/s00415-012-6686-0

K. Maeda, T. Shimbo, and T. Fukui, Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan, Journal of Medical Screening, vol.11, issue.2, pp.97-102, 2004.
DOI : 10.1258/096914104774061092

M. Jacobs, F. Kaasenbrood, M. Postma, M. Van-hulst, and R. Tieleman, Costeffectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands, Europace, 2016.

J. Yong, K. Thavorn, J. Hoch, M. Mamdani, K. Thorpe et al., Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke, Stroke, vol.47, issue.9, 2016.
DOI : 10.1161/STROKEAHA.115.011979

URL : http://stroke.ahajournals.org/content/strokeaha/47/9/2380.full.pdf

N. Lowres, L. Neubeck, G. Salkeld, I. Krass, A. Mclachlan et al., Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies, Thrombosis and Haemostasis, vol.111, issue.6, pp.1167-76, 2014.
DOI : 10.1160/TH14-03-0231

E. Benjamin, P. Wolf, R. Agostino, H. Silbershatz, W. Kannel et al., Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study, Circulation, vol.98, issue.10, pp.946-53, 1998.
DOI : 10.1161/01.CIR.98.10.946

P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar et al., 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Heart Journal, vol.37, issue.38, pp.2893-962, 2016.
DOI : 10.1093/eurheartj/ehw210

G. Lip, R. Nieuwlaat, R. Pisters, D. Lane, and H. Crijns, Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach, Chest, vol.137, issue.2, pp.263-72, 2010.
DOI : 10.1378/chest.09-1584

P. Kirchhof, G. Breithardt, J. Kuck, A. Vardas, P. Wegscheider et al., Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial, American Heart Journal, vol.166, issue.3, pp.442-450, 2013.
DOI : 10.1016/j.ahj.2013.05.015

K. Shinagawa, Y. Shi, J. Tardif, T. Leung, and S. Nattel, Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs, Circulation, vol.105, issue.22, pp.2672-2680, 2002.
DOI : 10.1161/01.CIR.0000016826.62813.F5

R. Page, W. Wilkinson, W. Clair, E. Mccarthy, and E. Pritchett, Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia, Circulation, vol.89, issue.1, pp.224-231, 1994.
DOI : 10.1161/01.CIR.89.1.224

T. Sanna, H. Diener, R. Passman, D. Lazzaro, V. Bernstein et al., Cryptogenic Stroke and Underlying Atrial Fibrillation, New England Journal of Medicine, vol.370, issue.26, pp.2478-86, 2014.
DOI : 10.1056/NEJMoa1313600

D. Gladstone, M. Spring, P. Dorian, V. Panzov, K. Thorpe et al., Atrial Fibrillation in Patients with Cryptogenic Stroke, New England Journal of Medicine, vol.370, issue.26, pp.2467-77, 2014.
DOI : 10.1056/NEJMoa1311376

J. Nasir, W. Pomeroy, A. Marler, M. Hann, T. Baykaner et al., Pre dicting D eterminants of A trial Fibrillation or Flutter for T herapy E lucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study, Heart Rhythm, vol.14, issue.7, pp.955-61, 2017.
DOI : 10.1016/j.hrthm.2017.04.026

J. Healey, M. Alings, P. Leong-sit, J. Degraff, D. Birnie et al., Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac monitor in Patients With Cardiovascular Risk Factors: ASSERT II. Abstr Present Am Hear Assoc Sci Sess 2016

J. Reiffel, A. Verma, P. Kowey, J. Halperin, B. Gersh et al., Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population, JAMA Cardiology, vol.2, issue.10, pp.1624-1654, 2017.
DOI : 10.1001/jamacardio.2017.3180

B. Freedman, Screening for Atrial Fibrillation, Circulation, vol.135, issue.19, pp.1851-67, 2017.
DOI : 10.1161/CIRCULATIONAHA.116.026693

R. Wakili, N. Voigt, S. Kääb, D. Dobrev, and S. Nattel, Recent advances in the molecular pathophysiology of atrial fibrillation, Journal of Clinical Investigation, vol.121, issue.8, pp.2955-68, 2011.
DOI : 10.1172/JCI46315

M. Haissaguerre, A. Shah, H. Cochet, M. Hocini, R. Dubois et al., Intermittent drivers anchoring to structural heterogenei-ties as a major pathophysiologic mechanism of human persistent atrial fibrillation, J Physiol, vol.9, pp.2387-98, 2016.

Y. Hu, Y. Chen, Y. Lin, and S. Chen, Inflammation and the pathogenesis of atrial fibrillation, Nature Reviews Cardiology, vol.51, issue.4, pp.230-273, 2015.
DOI : 10.1016/j.hlc.2014.02.003

M. Haïssaguerre, P. Jaïs, D. Shah, A. Takahashi, M. Hocini et al., Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins, New England Journal of Medicine, vol.339, issue.10, pp.659-66, 1998.
DOI : 10.1056/NEJM199809033391003

B. Nguyen, M. Fishbein, L. Chen, P. Chen, and S. Masroor, Histopathological substrate for chronic atrial fibrillation in humans, Heart Rhythm, vol.6, issue.4, pp.454-60, 2009.
DOI : 10.1016/j.hrthm.2009.01.010

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662134/pdf

M. Allessie, D. Groot, N. Houben, R. Schotten, U. Boersma et al., Electropathological Substrate of Long-Standing Persistent Atrial Fibrillation in Patients With Structural Heart Disease: Longitudinal Dissociation, Circulation: Arrhythmia and Electrophysiology, vol.3, issue.6, pp.606-621, 2010.
DOI : 10.1161/CIRCEP.109.910125

N. Voigt, J. Heijman, Q. Wang, D. Chiang, N. Li et al., Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial FibrillationCLINICAL PERSPECTIVE, Circulation, vol.129, issue.2, pp.145-56, 2014.
DOI : 10.1161/CIRCULATIONAHA.113.006641

L. Polontchouk, J. Haefliger, B. Ebelt, T. Schaefer, D. Stuhlmann et al., Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria, Journal of the American College of Cardiology, vol.38, issue.3, pp.883-91, 2001.
DOI : 10.1016/S0735-1097(01)01443-7

I. Fuller and M. Wood, Intramural Coronary Vasculature Prevents Transmural Radiofrequency Lesion Formation: Implications for Linear Ablation, Circulation, vol.107, issue.13, pp.1797-803, 2003.
DOI : 10.1161/01.CIR.0000058705.97823.F4

URL : http://circ.ahajournals.org/content/circulationaha/107/13/1797.full.pdf

L. S. Peng-sheng-chen, M. C. Chen, S. Fishbein, and S. Lin, Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

H. Lim, S. Willoughby, C. Schultz, C. Gan, M. Alasady et al., Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm, Journal of the American College of Cardiology, vol.61, issue.8, pp.852-60, 2013.
DOI : 10.1016/j.jacc.2012.11.046

S. Lubitz, K. Lunetta, H. Lin, D. Arking, S. Trompet et al., Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese, Journal of the American College of Cardiology, vol.63, issue.12, pp.1200-1210, 2014.
DOI : 10.1016/j.jacc.2013.12.015

URL : https://doi.org/10.1016/j.jacc.2013.12.015

W. Feinberg, J. Blackshear, R. Kronmal, and R. Hart, Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation, Archives of Internal Medicine, vol.155, issue.5, pp.469-73, 2015.
DOI : 10.1001/archinte.1995.00430050045005

J. Heeringa, V. D. Kuip, D. Hofman, A. Kors, J. Van-herpen et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, European Heart Journal, vol.27, issue.8, pp.949-53, 2006.
DOI : 10.1093/eurheartj/ehi825

L. , D. Wang, T. Leip, E. Larson, M. Levy et al., Lifetime risk for development of atrial fibrillation: The framingham heart study Prevalence of Diagnosed Atrial Fibrillation in Adults, 2370. 35. HAS. Synthèse, Guide Parcours De Soins Fibrillation Atriale (Fa), pp.1042-61, 2001.

R. Schnabel, X. Yin, P. Gona, M. Larson, A. Beiser et al., 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study, The Lancet, vol.386, issue.9989, pp.154-62, 2015.
DOI : 10.1016/S0140-6736(14)61774-8

A. Esc, Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice G, Circulation, vol.114, issue.7, pp.257-354, 2006.

C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa et al., ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society, AHA J Am Coll Cardiol, vol.64, issue.21, pp.2245-80, 2014.

P. Wolf, T. Dawber, H. Thomas, and W. Kannel, Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study, Neurology, vol.77, issue.16, pp.973-980, 1978.
DOI : 10.1212/01.wnl.0000407150.80523.a4

H. Autorité and D. Santé, Guide parcours de soin: fibrillation atriale, Guid Parcour Soins, pp.1-75, 2014.

D. Holmes, S. Doshi, S. Kar, M. Price, J. Sanchez et al., Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation, Journal of the American College of Cardiology, vol.65, issue.24, pp.2614-2637, 2015.
DOI : 10.1016/j.jacc.2015.04.025

P. Bernhardt, H. Schmidt, C. Hammerstingl, B. Lüderitz, and H. Omran, Patients With Atrial Fibrillation and Dense Spontaneous Echo Contrast at High Risk, Journal of the American College of Cardiology, vol.45, issue.11, pp.1807-1819, 2005.
DOI : 10.1016/j.jacc.2004.11.071

URL : https://doi.org/10.1016/j.jacc.2004.11.071

M. Sinner, K. Stepas, C. Moser, B. Krijthe, T. Aspelund et al., B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies, EP Europace, vol.16, issue.10, pp.1426-1459, 2014.
DOI : 10.1093/europace/euu175

R. Hart, L. Pearce, and M. Aguilar, Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation, Annals of Internal Medicine, vol.146, issue.12, pp.857-67, 1997.
DOI : 10.7326/0003-4819-146-12-200706190-00007

R. Hart, L. Pearce, and M. Aguilar, Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial Fibrillation, Annals of Internal Medicine, vol.147, issue.8, pp.590-592, 2007.
DOI : 10.7326/0003-4819-147-8-200710160-00018

J. Mant, R. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice et al., Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007.
DOI : 10.1016/S0140-6736(07)61233-1

C. Ruff, R. Giugliano, E. Braunwald, E. Hoffman, N. Deenadayalu et al., Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, The Lancet, vol.383, issue.9921, pp.955-62, 2014.
DOI : 10.1016/S0140-6736(13)62343-0

URL : https://hal.archives-ouvertes.fr/hal-00935589

M. Brambatti, S. Connolly, M. Gold, C. Morillo, A. Capucci et al., Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events, Circulation, vol.129, issue.21, pp.2094-2103, 2014.
DOI : 10.1161/CIRCULATIONAHA.113.007825

URL : http://circ.ahajournals.org/content/circulationaha/129/21/2094.full.pdf

B. Larsen, P. Kumarathurai, J. Falkenberg, O. Nielsen, and A. Sajadieh, Excessive Atrial Ectopy and Short Atrial Runs??Increase the Risk of Stroke??Beyond Incident??Atrial Fibrillation, Journal of the American College of Cardiology, vol.66, issue.3, pp.232-273, 2015.
DOI : 10.1016/j.jacc.2015.05.018

N. Roskell, M. Samuel, H. Noack, and B. Monz, Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies, EP Europace, vol.15, issue.6, pp.787-97, 2014.
DOI : 10.1093/europace/eut001

R. Pisters, D. Lane, R. Nieuwlaat, D. Vos, C. Crijns et al., A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest, vol.138, issue.5, pp.1093-100, 2010.
DOI : 10.1378/chest.10-0134

B. Gage, Y. Yan, P. Milligan, A. Waterman, R. Culverhouse et al., Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), American Heart Journal, vol.151, issue.3, pp.713-722, 2006.
DOI : 10.1016/j.ahj.2005.04.017

O. Brien, E. Simon, D. Thomas, L. Hylek, E. Gersh et al., The ORBIT bleeding score: A simple bedside score to assess bleeding risk in atrial fibrillation, Eur Heart J, vol.36, issue.46, pp.3258-64, 2015.

Z. Hijazi, J. Oldgren, J. Lindbäck, J. Alexander, S. Connolly et al., The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study, The Lancet, vol.387, issue.10035, pp.2302-2313, 2016.
DOI : 10.1016/S0140-6736(16)00741-8

L. Fauchier, G. Chaize, A. Gaudin, A. Vainchtock, S. Rushton-smith et al., Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study, International Journal of Cardiology, vol.217, pp.85-91, 2016.
DOI : 10.1016/j.ijcard.2016.04.173

J. Ruiz-nodar, F. Marín, J. Hurtado, J. Valencia, E. Pinar et al., Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation, Journal of the American College of Cardiology, vol.51, issue.8, pp.818-843, 2008.
DOI : 10.1016/j.jacc.2007.11.035

URL : https://doi.org/10.1016/j.jacc.2007.11.035

M. Hughes and G. Lip, Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review, QJM, vol.100, issue.10, pp.599-607, 2007.
DOI : 10.1093/qjmed/hcm076

M. Ezekowitz, Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation, Arch Intern Med, vol.158, issue.12, p.1316, 1998.

K. Peters and M. Kienzle, Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm, The American Journal of Medicine, vol.85, issue.2, pp.242-246, 1988.
DOI : 10.1016/S0002-9343(88)80352-8

L. Hsu, P. Jais, P. Sanders, S. Garrigue, M. Hocini et al., Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure, New England Journal of Medicine, vol.351, issue.23, pp.2373-83, 2004.
DOI : 10.1056/NEJMoa041018

T. Fetsch, P. Bauer, R. Engberding, H. Koch, J. Lukl et al., Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial, European Heart Journal, vol.25, issue.16, pp.1385-94, 2004.
DOI : 10.1016/j.ehj.2004.04.015

J. Wilson and G. Jungner, Principes et pratique du dépistage des maladies. Organisation Mondiale de la Santé, 1970.

M. Jenicek and R. Cléroux, Épidémiologie: principes, techniques, applications, 1982.

R. Hart, L. Pearce, R. Rothbart, J. Mcanulty, R. Asinger et al., Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy, Journal of the American College of Cardiology, vol.35, issue.1, pp.183-190, 2000.
DOI : 10.1016/S0735-1097(99)00489-1

URL : https://doi.org/10.1016/s0735-1097(99)00489-1

J. Healey, S. Connolly, M. Gold, C. Israel, V. Gelder et al., Subclinical Atrial Fibrillation and the Risk of Stroke, New England Journal of Medicine, vol.366, issue.2, pp.120-129, 2012.
DOI : 10.1056/NEJMoa1105575

L. Friberg, M. Rosenqvist, A. Lindgren, A. Terént, B. Norrving et al., High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke, Stroke, vol.45, issue.9, pp.2549-605, 2014.
DOI : 10.1161/STROKEAHA.114.006070

B. Freedman, T. Potpara, and G. Lip, Stroke prevention in atrial fibrillation, The Lancet, vol.388, issue.10046, pp.806-823, 2016.
DOI : 10.1016/S0140-6736(16)31257-0

C. Martinez, A. Katholing, and S. Freedman, Adverse prognosis of incidentally detected ambulatory atrial fibrillation, Thrombosis and Haemostasis, vol.112, issue.2, pp.276-86, 2014.
DOI : 10.1160/TH4-04-0383

B. Freedman, C. Martinez, A. Katholing, S. Rietbrock, V. F. et al., Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation, JAMA Cardiology, vol.1, issue.3, p.366, 2016.
DOI : 10.1001/jamacardio.2016.0393

B. Freedman, C. Martinez, A. Katholing, and S. Rietbrock, Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation, JAMA Cardiology, vol.1, issue.3, pp.4-5, 2016.
DOI : 10.1001/jamacardio.2016.0393

H. Tu, S. Spence, J. Kalman, and S. Davis, Twenty-eight day Holter monitoring is poorly tolerated and insensitive for paroxysmal atrial fibrillation detection in cryptogenic stroke, Internal Medicine Journal, vol.22, issue.5, pp.505-513, 2014.
DOI : 10.1016/j.jstrokecerebrovasdis.2012.08.010

B. Freedman, C. Martinez, A. Katholing, and S. Rietbrock, Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation, JAMA Cardiology, vol.1, issue.3, p.366, 2016.
DOI : 10.1001/jamacardio.2016.0393

L. Benito, B. Coll-vinent, E. Gó-mez, D. Martí, J. Mitjavila et al., EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. 76 Prevalence of unknown atrial fibrillation in patients with risk factors, EP Eur. mai, vol.15, issue.5, pp.657-62, 2013.

G. Cooke, J. Doust, and S. Sanders, Is pulse palpation helpful in detecting atrial fibrillation? A systematic review, J Fam Pract. févr, vol.55, issue.2, pp.130-134, 2006.

D. Fitzmaurice, F. Hobbs, S. Jowett, J. Mant, E. Murray et al., Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial, BMJ, vol.335, issue.7616, p.383, 2007.
DOI : 10.1136/bmj.39280.660567.55

J. Engdahl, L. Andersson, M. Mirskaya, and M. Rosenqvist, Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention, Circulation, vol.127, issue.8, pp.930-937, 2013.
DOI : 10.1161/CIRCULATIONAHA.112.126656

G. Manina, G. Agnelli, C. Becattini, G. Zingarini, and M. Paciaroni, 96??hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack, Internal and Emergency Medicine, vol.20, issue.6, pp.65-72, 2014.
DOI : 10.4061/2011/172074

P. Barrett, R. Komatireddy, S. Haaser, S. Topol, J. Sheard et al., Comparison of 24-hour Holter Monitoring with 14-day Novel Adhesive Patch Electrocardiographic Monitoring, The American Journal of Medicine, vol.127, issue.1, pp.95-106, 2014.
DOI : 10.1016/j.amjmed.2013.10.003

M. Turakhia, A. Ullal, D. Hoang, C. Than, J. Miller et al., Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF), Clinical Cardiology, vol.158, issue.2 suppl, pp.285-92, 2015.
DOI : 10.1016/j.ahj.2009.07.002

F. Hobbs, C. Taylor, J. Geersing, G. Rutten, F. Brouwer et al., European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care, European Journal of Preventive Cardiology, vol.23, issue.5, pp.460-73, 2016.
DOI : 10.1093/europace/eut083

K. Kearley, M. Selwood, A. Van-den-bruel, M. Thompson, D. Mant et al., Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors, BMJ Open, vol.42, issue.(Suppl 18), p.4565, 2014.
DOI : 10.1016/S0140-6736(12)61728-0

M. Lewis, D. Parker, C. Weston, and M. Bowes, Screening for atrial fibrillation: sensitivity and specificity of a new methodology, British Journal of General Practice, vol.61, issue.582, pp.38-47, 2011.
DOI : 10.3399/bjgp11X548956

E. Svennberg, J. Engdahl, F. Al-khalili, L. Friberg, V. Frykman et al., Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study, Circulation, vol.131, issue.25, pp.2176-84, 2015.
DOI : 10.1161/CIRCULATIONAHA.114.014343

URL : http://circ.ahajournals.org/content/circulationaha/131/25/2176.full.pdf

P. Doliwa, V. Frykman, and M. Rosenqvist, Short-term ECG for out of hospital detection of silent atrial fibrillation episodes, Scandinavian Cardiovascular Journal, vol.2007, issue.3, pp.163-171, 2009.
DOI : 10.1111/j.1540-8159.2004.00502.x

J. Lau, N. Lowres, L. Neubeck, D. Brieger, R. Sy et al., iPhone ECG application for community screening to detect silent atrial fibrillation: A novel technology to prevent stroke, International Journal of Cardiology, vol.165, issue.1, pp.193-197, 2013.
DOI : 10.1016/j.ijcard.2013.01.220

B. Vaes, S. Stalpaert, K. Tavernier, B. Thaels, D. Lapeire et al., The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care, BMC Family Practice, vol.335, issue.suppl 18, p.113, 2014.
DOI : 10.1136/bmj.39227.551713.AE

G. Marazzi, F. Iellamo, M. Volterrani, M. Lombardo, F. Pelliccia et al., Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients, Advances in Therapy, vol.43, issue.1, pp.64-70, 2012.
DOI : 10.1016/j.jacc.2003.08.027

J. Wiesel, B. Arbesfeld, and D. Schechter, Comparison of the Microlife Blood Pressure Monitor With the Omron Blood Pressure Monitor for Detecting Atrial Fibrillation, The American Journal of Cardiology, vol.114, issue.7, pp.1046-1054, 2014.
DOI : 10.1016/j.amjcard.2014.07.016

D. Mcmanus, J. Chong, A. Soni, J. Saczynski, N. Esa et al., PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application, Journal of Cardiovascular Electrophysiology, vol.105, issue.Suppl 1, pp.51-58, 2016.
DOI : 10.1016/S0735-1097(13)60362-9

R. Tieleman, Y. Plantinga, D. Rinkes, G. Bartels, J. Posma et al., Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation, Europace, vol.16, issue.9, pp.1291-1296, 2014.
DOI : 10.1093/europace/euu057

M. Turakhia, J. Shafrin, K. Bognar, D. Goldman, P. Mendys et al., Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States, The American Journal of Cardiology, vol.116, issue.5, pp.733-742, 2015.
DOI : 10.1016/j.amjcard.2015.05.045

F. Hobbs, D. Fitzmaurice, J. Mant, E. Murray, S. Jowett et al., A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study, Health Technology Assessment, vol.9, issue.40, 2005.
DOI : 10.3310/hta9400

M. Aronsson, E. Svennberg, M. Rosenqvist, J. Engdahl, F. Al-khalili et al., Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording, Europace, vol.17, issue.7, pp.1023-1032, 2015.
DOI : 10.1093/europace/euv083

J. Lian, L. Wang, and D. Muessig, A Simple Method to Detect Atrial Fibrillation Using RR Intervals, The American Journal of Cardiology, vol.107, issue.10, pp.1494-1501, 2011.
DOI : 10.1016/j.amjcard.2011.01.028

A. Schäfer and J. Vagedes, How accurate is pulse rate variability as an estimate of heart rate variability?, International Journal of Cardiology, vol.166, issue.1, pp.15-29, 2013.
DOI : 10.1016/j.ijcard.2012.03.119

D. Linker and . Accurate, Accurate, Automated Detection of Atrial Fibrillation in Ambulatory Recordings, Cardiovascular Engineering and Technology, vol.39, issue.6, pp.182-191, 2016.
DOI : 10.1007/BF02345439

S. Sarkar, D. Ritscher, and R. Mehra, A Detector for a Chronic Implantable Atrial Tachyarrhythmia Monitor, IEEE Transactions on Biomedical Engineering, vol.55, issue.3, pp.1219-1243, 2008.
DOI : 10.1109/TBME.2007.903707

D. Lake, Improved entropy rate estimation in physiological data, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.1463-1469, 2011.
DOI : 10.1109/IEMBS.2011.6090339

T. V. Glotzer, E. Daoud, D. Wyse, D. Singer, M. Ezekowitz et al., The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study, Circulation: Arrhythmia and Electrophysiology, vol.2, issue.5, pp.474-80, 2009.
DOI : 10.1161/CIRCEP.109.849638

URL : http://circep.ahajournals.org/content/circae/2/5/474.full.pdf

L. Sposato, L. Cipriano, G. Saposnik, E. Vargas, P. Riccio et al., Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis, The Lancet Neurology, vol.14, issue.4, pp.377-87, 2015.
DOI : 10.1016/S1474-4422(15)70027-X

D. Gladstone, E. Bui, J. Fang, A. Laupacis, M. Lindsay et al., Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated, Stroke, vol.40, issue.1, pp.235-275, 2009.
DOI : 10.1161/STROKEAHA.108.516344

URL : http://stroke.ahajournals.org/content/strokeaha/40/1/235.full.pdf

J. Hsu, T. Maddox, K. Kennedy, D. Katz, L. Marzec et al., Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk, JAMA Cardiology, vol.1, issue.1, pp.1-8, 2016.
DOI : 10.1001/jamacardio.2015.0374